Cabot (NYSE:CBT) Price Target Raised to $70.00

Cabot (NYSE:CBT) had its target price hoisted by research analysts at JPMorgan Chase & Co. from $68.00 to $70.00 in a research note issued on Wednesday,Benzinga reports. The brokerage presently has an “underweight” rating on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s target price would indicate a potential downside of 16.01% from the stock’s current price.

Other analysts also recently issued research reports about the stock. Mizuho lifted their price target on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research note on Saturday. UBS Group lifted their price target on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday. Jefferies Financial Group reaffirmed a “buy” rating and set a $85.00 price target on shares of Cabot in a research note on Wednesday, February 4th. Finally, Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 27th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus target price of $80.25.

Cabot Trading Down 1.4%

NYSE CBT traded down $1.19 during trading on Wednesday, hitting $83.34. The stock had a trading volume of 52,938 shares, compared to its average volume of 435,073. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The stock has a market capitalization of $4.30 billion, a price-to-earnings ratio of 15.75, a P/E/G ratio of 11.18 and a beta of 0.78. Cabot has a one year low of $58.33 and a one year high of $86.43. The stock has a 50 day simple moving average of $74.48 and a 200 day simple moving average of $70.73.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.31 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Sell-side analysts predict that Cabot will post 6.25 earnings per share for the current year.

Hedge Funds Weigh In On Cabot

A number of large investors have recently bought and sold shares of the business. Fuller & Thaler Asset Management Inc. raised its stake in Cabot by 5.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after buying an additional 124,613 shares in the last quarter. State Street Corp grew its holdings in Cabot by 1.0% in the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after purchasing an additional 20,021 shares during the last quarter. American Century Companies Inc. grew its holdings in Cabot by 8.4% in the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after purchasing an additional 140,665 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Cabot by 4.8% in the first quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock worth $131,253,000 after purchasing an additional 79,499 shares during the last quarter. Finally, Bank of America Corp DE grew its holdings in Cabot by 3.9% in the third quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after purchasing an additional 63,080 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.